西班牙肺癌协作组 SLCG
肺癌研究组 Lung Cancer Study Group ; VALG ; LCRG ; Veterans Administration Lung Study Group
国际肺癌研究组织 IASLC ; International Association of Lung Cancer
非小细胞肺癌协作组 NSCLCCG
据肺癌研究组 Lung Cancer Study Group ; LCSG
根据肺癌研究组 Lung Cancer Study Group ; LCSG
肺癌研究小组 Lung Cancer Study Group ; LCSG
肺癌疾病部位组 Lung Cancer Disease Site Group
国际辅助肺癌研究组 International Adjuvant Lung Cancer Trial ; IALT
结论CYP2A6突变基因在肺癌组及对照组中的频率分布没有差异。
Conclusion There is no difference in frequency of CYP2A6 gene deletion between lung cancer cases and controls.
方法采用电化学发光法(ECLIA)分别对肺癌组、肺部良性疾病组患者及健康人的血清肿瘤标记物浓度进行检测分析。
Methods Serum tumor markers of lung cancer group, benign disease group and health control group were detected by chemiluminescence immunoassay (ECLIA).
方法用PCR-RFLP技术分析了原发性肺癌组和住院对照组（各163例）的CYP1A1、GSTM1基因的多态性、基因型分布频率和交互作用。
Methods CYP1A1 and GSTM1 genetic polymorphisms were determined by PCR-RFLP in 163 lung cancer cases and healthy controls respectively.
应用推荐